Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Goodyear Tire & Rubber Co (GT) Price & Performance

Cassava Sciences IncTrade
Goodyear Tire & Rubber CoTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Goodyear Tire & Rubber Co — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Goodyear Tire & Rubber Co trades at $4.79 (market cap $1.37B). The key difference: Goodyear Tire & Rubber Co is far larger — about 34.8× Cassava Sciences Inc's market cap, and Cassava Sciences Inc is more actively traded (759,018 versus 9,470,773). Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Goodyear Tire & Rubber Co for 57 Days on average.

FLNAGT
Market Cap
$39.40M$1.37B
Volume
759,0189,470,773
Sector
HealthConsumer Cyclical
52-Week High
$4.64$10.54
52-Week Low
$0.68$4.66
Typical Hold Time
37 Days57 Days
Enterprise Value
-$43.28M$8.72B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.

The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.

Goodyear Tire & Rubber Co

The Goodyear Tire & Rubber Company (GT) trades at $4.69, near its 52-week low, with a bearish technical signal and mixed earnings history. Despite beating EPS estimates in two recent quarters, the company reported a net loss of $1.72 billion in 2025, with negative profit margins and ROE. Cash flow improved slightly in 2025, but high debt levels and declining revenue pose challenges. Recent news highlights restructuring efforts and a 'shrink-to-grow' strategy targeting premium tire segments.

GT presents a high-risk opportunity with a deep value proposition—low P/E and P/B ratios suggest undervaluation, but persistent losses and bearish analyst sentiment indicate significant headwinds. The stock's upside hinges on successful execution of its turnaround plan and margin improvement, while downside risks include ongoing volume pressure and macroeconomic pressures on the auto industry.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLNA
73% Buy27% Sell
Avg holding period · 37 Days
GT
100% Buy0% Sell
Avg holding period · 57 Days

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA →

About Goodyear Tire & Rubber Co

Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.

Read more on GT →